Canopy announced that its EHR-integrated Remote Therapeutic Monitoring (RTM) Platform significantly reduced infection-related hospitalizations in hematology patients, with a 48% relative risk reduction. The study's findings will be presented at the 2025 ASH Annual Meeting, emphasizing the platform's ability to identify symptoms early and prompt outpatient treatment. This development underscores Canopy’s growing role in enhancing oncology patient care through AI-driven remote monitoring.